These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25861950)

  • 1. A novel peptide for efficient siRNA delivery in vitro and therapeutics in vivo.
    Pan R; Xu W; Yuan F; Chu D; Ding Y; Chen B; Jafari M; Yuan Y; Chen P
    Acta Biomater; 2015 Jul; 21():74-84. PubMed ID: 25861950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of endosomolytic biocompatible peptides as carriers for siRNA delivery.
    Xu W; Pan R; Zhao D; Chu D; Wu Y; Wang R; Chen B; Ding Y; Sadatmousavi P; Yuan Y; Chen P
    Mol Pharm; 2015 Jan; 12(1):56-65. PubMed ID: 25378277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disulfide crosslinked stearoyl carrier peptides containing arginine and histidine enhance siRNA uptake and gene silencing.
    Tanaka K; Kanazawa T; Ogawa T; Takashima Y; Fukuda T; Okada H
    Int J Pharm; 2010 Oct; 398(1-2):219-24. PubMed ID: 20674725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective small interfering RNA delivery in vitro via a new stearylated cationic peptide.
    Chen B; Pan R; Askhatova D; Chen P
    Int J Nanomedicine; 2015; 10():3303-14. PubMed ID: 25999710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly branched HK peptides are effective carriers of siRNA.
    Leng Q; Scaria P; Zhu J; Ambulos N; Campbell P; Mixson AJ
    J Gene Med; 2005 Jul; 7(7):977-86. PubMed ID: 15772938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers.
    Ofek P; Fischer W; Calderón M; Haag R; Satchi-Fainaro R
    FASEB J; 2010 Sep; 24(9):3122-34. PubMed ID: 20385622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery.
    Wan Y; Moyle PM; Gn PZ; Toth I
    Nanomedicine (Lond); 2017 Feb; 12(4):281-293. PubMed ID: 28093948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable stearylated peptide with internal disulfide bonds for efficient delivery of siRNA in vitro and in vivo.
    Tai Z; Wang X; Tian J; Gao Y; Zhang L; Yao C; Wu X; Zhang W; Zhu Q; Gao S
    Biomacromolecules; 2015 Apr; 16(4):1119-30. PubMed ID: 25686200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.
    Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A
    Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEG-detachable cationic polyaspartamide derivatives bearing stearoyl moieties for systemic siRNA delivery toward subcutaneous BxPC3 pancreatic tumor.
    Kim HJ; Oba M; Pittella F; Nomoto T; Cabral H; Matsumoto Y; Miyata K; Nishiyama N; Kataoka K
    J Drug Target; 2012 Jan; 20(1):33-42. PubMed ID: 22066783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference in vitro and in vivo using an arginine peptide/siRNA complex system.
    Kim SW; Kim NY; Choi YB; Park SH; Yang JM; Shin S
    J Control Release; 2010 May; 143(3):335-43. PubMed ID: 20079391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery.
    Yang Y; Yang Y; Xie X; Wang Z; Gong W; Zhang H; Li Y; Yu F; Li Z; Mei X
    Biomaterials; 2015 Apr; 48():84-96. PubMed ID: 25701034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mPEG-PLGA-b-PLL copolymer carrier for adriamycin and siRNA delivery.
    Liu P; Yu H; Sun Y; Zhu M; Duan Y
    Biomaterials; 2012 Jun; 33(17):4403-12. PubMed ID: 22436800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEGylation Enhanced the Stability of Peptide-siRNA Complexes in Serum.
    Pan R; Xu W; Jafari M; Chen B; Sheinin T; Chen P
    J Nanosci Nanotechnol; 2015 Dec; 15(12):9982-90. PubMed ID: 26682443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
    Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
    Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of ionizable peptide amphiphiles for siRNA delivery.
    Neuberg P; Wagner A; Remy JS; Kichler A
    Int J Pharm; 2019 Jul; 566():141-148. PubMed ID: 31125716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of therapeutic shRNA and siRNA by Tat fusion peptide targeting BCR-ABL fusion gene in Chronic Myeloid Leukemia cells.
    Arthanari Y; Pluen A; Rajendran R; Aojula H; Demonacos C
    J Control Release; 2010 Aug; 145(3):272-80. PubMed ID: 20403398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Amphipathic Structure of a Dipropylglycine-Containing Helical Peptide with Sufficient Length Enables Safe and Effective Intracellular siRNA Delivery.
    Oba M; Shibuya M; Yamaberi Y; Yokoo H; Uchida S; Ueda A; Tanaka M
    Chem Pharm Bull (Tokyo); 2023; 71(3):250-256. PubMed ID: 36858531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.